
VIP
VP10 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to QuoteAnswer-first product list with quote-ready specifications and research-use boundaries.

VP10 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
XA5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SK5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SSXK 20 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
Pin 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
P215 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ET10 40 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
DR5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
DS2 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
RA10 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ARA16 16 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ACTH5 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
P21 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote